Ensitrelvir, an oral SARS-CoV-2 3C-like protease inhibitor, reduced symptomatic RT-PCR-confirmed COVID-19 among household ...
Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...
A new study led by researchers at the University of Malaga proposes a new antiviral strategy against SARS-CoV-2—the virus ...
BA.3.2 spread internationally after first being identified in South Africa in November 2024, with detections rising from September 2025 and reports from at least 23 countries by 11 February 2026. U.S.
Live Science on MSN
A pill can stop people from developing COVID after being exposed to the virus, trial finds
A pill called ensitrelvir is the first drug shown to effectively reduce infection after exposure to SARS-CoV-2.
A new variant of the SARS-CoV-2 virus, dubbed Cicada, is less susceptible to vaccination and appears to discriminate based on ...
The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...
Sinar Daily on MSN
Coronavirus no longer poses serious threat - virologist
Herd immunity has already developed worldwide.
25y
Covid 19
Read Latest News on Covid 19 along with top headlines and breaking news today. Also get Covid 19 Updates, Photos and Videos at Hindustan Times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results